HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US FDA Turns To Temporary Enforcement Discretion For Boosting Infant Formula Supply

Agency Also Allows Abbott Facility To Restart Production Under Consent Decree

Executive Summary

FDA launches temporary enforcement discretion on infant formula product to help increase supply in US on same day consent decree announced to allow Abbott to restart production at facility closed since February, prompting ongoing formula shortage. 

You may also be interested in...



USDA Examines Potential Production Regulation Changes To Prevent Powder Formula Contamination

USDA Food Safety and Inspection Service’s National Advisory Committee on Microbiological Criteria for Foods schedules hearing for 15 November to consider a report from FDA on presence of Cronobacter species bacteria in powder formula products.

Abbott Concludes Former Employees’ Allegations Concerning Michigan Formula Plant ‘Unfounded’

Abbott’s Q3 worldwide sales of formula and other pediatric nutritionals were down 24.8% on reported basis. It plans spending $500m on a new formula facility after finding the US “would benefit from more manufacturing capacity and redundancy.”

Infant Formula Shipped From Texas Strip Mall Without Sufficient Bacteria Testing

FDA says Mother’s Touch Formula made available without pre-market notification and with essential nutrients below required levels. Marketer’s address is a strip mall with fast food restaurants, hair salon, postal services business, grocery store and congressional candidate’s campaign office.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

RS152526

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel